Tang Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.4M | Hold |
1,500,000
| – | – | 1.64% | 14 |
|
|
2025
Q1 | $24.9M | Hold |
1,500,000
| – | – | 1.38% | 17 |
|
|
2024
Q4 | $27.5M | Hold |
1,500,000
| – | – | 1.82% | 13 |
|
|
2024
Q3 | $23.1M | Hold |
1,500,000
| – | – | 1.65% | 16 |
|
|
2024
Q2 | $24.4M | Buy |
1,500,000
+981,100
| +189% | +$15.9M | 2.48% | 9 |
|
|
2024
Q1 | $9.59M | Buy |
518,900
+404,500
| +354% | +$7.48M | 1% | 35 |
|
|
2023
Q4 | $3.58M | Buy |
114,400
+14,400
| +14% | +$451K | 0.33% | 71 |
|
|
2023
Q3 | $2.08M | Buy |
+100,000
| New | +$2.08M | 0.29% | 69 |
|